Antibiotic therapy and metabolism in lung cancer patients receiving checkpoint inhibitors

被引：0
|
作者：
Castello, Angelo [1 ]
Rossi, Sabrina [2 ]
Toschi, Luca [3 ]
Lopci, Egesta [2 ]
机构：
[1] Ist Clin Humanitas, Rozzano, MI, Italy
[2] Humanitas Res Hosp, Rozzano, Italy
[3] Humanitas Clin & Res Ctr, Rozzano, MI, Italy
来源：
JOURNAL OF NUCLEAR MEDICINE | 2020年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
238
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Survival outcomes of patients with nonsmall cell lung cancer concomitantly receiving proton pump inhibitors and immune checkpoint inhibitors
    Baek, Yeon-Hee
    Kang, Eun Joo
    Hong, Soojung
    Park, Sohee
    Kim, Ju Hwan
    Shin, Ju-Young
    INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (08) : 1291 - 1300
  • [22] Cardiotoxicity of Immune Checkpoint Inhibitors in Patients with Lung Cancer
    Chitturi, Kalyan R.
    Araujo-Gutierrez, Raquel
    McLean, Edward T.
    Xu, Jiaqiong
    Bhimaraj, Arvind
    Guha, Ashrith
    Hussain, Imad
    Trachtenberg, Barry H.
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S50 - S50
  • [23] Identification of prognostic factors and nomogram model for patients with advanced lung cancer receiving immune checkpoint inhibitors
    Chen, Xiuqiong
    Li, Zhaona
    Zhou, Jing
    Wei, Qianhui
    Wang, Xinyue
    Jiang, Richeng
    PEERJ, 2022, 10
  • [24] CARDIAC IMMUNE-RELATED ADVERSE EVENTS IN LUNG CANCER PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS
    Kumar, Sany
    Fowler, Cosmo
    Thota, Ajit K.
    Pastores, Stephen M.
    CHEST, 2023, 164 (04) : 363A - 363A
  • [25] Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors
    Catalano, Martina
    Fancelli, Sara
    Caliman, Enrico
    Mazzoni, Francesca
    Michelet, Marta Gatta
    Mancini, Silvia
    Manneschi, Clara
    Shabani, Sonia
    Napolitano, Brunella
    Pillozzi, Serena
    Antonuzzo, Lorenzo
    Roviello, Giandomenico
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [26] Pulmonary Complications and Bronchoscopy Utilization in Patients With Lung Cancer Receiving Immune Checkpoint Inhibitor Therapy
    Bae, J.
    Lee, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [27] Emerging concern of infectious diseases in lung cancer patients receiving immune checkpoint inhibitor therapy
    Fujita, Kohei
    Kanai, Osamu
    Kim, Young Hak
    Yoshida, Hironori
    Mio, Tadashi
    Hirai, Toyohiro
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [28] Emerging concerns of infectious diseases in lung cancer patients receiving immune checkpoint inhibitor therapy
    Fujita, Kohei
    Kim, Young Hak
    Kanai, Osamu
    Yoshida, Hironori
    Mio, Tadashi
    Hirai, Toyohiro
    RESPIRATORY MEDICINE, 2019, 146 : 66 - 70
  • [29] Predictive biomarkers for immune checkpoint inhibitors therapy in lung cancer
    Yao, Jie
    Lin, Xuwen
    Zhang, Xin
    Xie, Mei
    Ma, Xidong
    Bao, Xinyu
    Song, Jialin
    Liang, Yiran
    Wang, Qiqi
    Xue, Xinying
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [30] Clinical features of immune checkpoint inhibitor-related pneumonitis in older patients with lung cancer receiving immune checkpoint inhibitors-based therapy: a retrospective study
    Jiafan Liu
    Dongmei Zhou
    Na Wu
    Jia Liu
    Xiaonan Wang
    BMC Geriatrics, 25 (1)
12345